tiprankstipranks
Advertisement
Advertisement

CHRO Stock Latest News

Nurix Therapeutics price target raised to $34 from $32 at Truist
The FlyNurix Therapeutics price target raised to $34 from $32 at Truist
17h ago
CHRO
NRIX
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
PremiumThe Fly
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
17h ago
CHRO
NRIX
Roche receives CE Mark for blood test to identify tuberculosis infection
PremiumThe Fly
Roche receives CE Mark for blood test to identify tuberculosis infection
2d ago
CHRO
Roche downgraded to Hold from Buy at HSBC
PremiumThe Fly
Roche downgraded to Hold from Buy at HSBC
5d ago
CHRO
Genentech announces Krascendo 1 study met primary, key secondary endpoint
PremiumThe Fly
Genentech announces Krascendo 1 study met primary, key secondary endpoint
9d ago
CHRO
AI Daily: Amazon’s AWS commits $1B toward new unit
PremiumThe FlyAI Daily: Amazon’s AWS commits $1B toward new unit
11d ago
AZN
BMY
Anthropic takes aim at pharma industry with Claude Science, STAT reports
Premium
The Fly
Anthropic takes aim at pharma industry with Claude Science, STAT reports
11d ago
AZN
BMY
Genentech announces priority review for Enspryng
Premium
The Fly
Genentech announces priority review for Enspryng
11d ago
CHRO
Roche announces launch of AXELIOS 1, a next-gen sequencing platform
PremiumThe Fly
Roche announces launch of AXELIOS 1, a next-gen sequencing platform
12d ago
CHRO
Sanofi investors likely to view new R&D head as a positive, says BofA
PremiumThe Fly
Sanofi investors likely to view new R&D head as a positive, says BofA
19d ago
SNY
CHRO
Nurix Therapeutics price target raised to $33 from $26 at Baird
PremiumThe Fly
Nurix Therapeutics price target raised to $33 from $26 at Baird
23d ago
CHRO
NRIX
Genentech says FDA accepts sBLA for for Lunsumio VELO
PremiumThe Fly
Genentech says FDA accepts sBLA for for Lunsumio VELO
23d ago
CHRO
FDA approves generic of Genentech’s Xofluza tablets
PremiumThe FlyFDA approves generic of Genentech’s Xofluza tablets
23d ago
CHRO
CMS proposes to lock in lower prices in Medicare drug price negotiation program
Premium
The Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
26d ago
AZN
BMY
Roche reports FDA approval for prostate cancer companion diagnostic
Premium
The Fly
Roche reports FDA approval for prostate cancer companion diagnostic
28d ago
AZN
CHRO
OraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit
PremiumThe Fly
OraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit
30d ago
CHRO
OSUR
Genentech granted priority review for Tecentriq Hybreza combination
PremiumThe Fly
Genentech granted priority review for Tecentriq Hybreza combination
30d ago
CHRO
Roche announces EU IVDR approval of several Ventana label expansions
PremiumThe Fly
Roche announces EU IVDR approval of several Ventana label expansions
30d ago
CHRO
Nurix Therapeutics price target raised to $32 from $30 at Truist
PremiumThe Fly
Nurix Therapeutics price target raised to $32 from $30 at Truist
1M ago
CHRO
NRIX
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
PremiumThe FlyNurix Therapeutics price target raised to $45 from $41 at Jefferies
1M ago
CHRO
NRIX
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
Premium
The Fly
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
1M ago
CHRO
NRIX
Video: Marvell, Flex rise after selection for S&P 500
Premium
The Fly
Video: Marvell, Flex rise after selection for S&P 500
1M ago
CPB
LLY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >